Sandra Morissette

Sandra Morissette has a diverse work experience in the field of research and science. Sandra is currently working at Congruence Therapeutics as a Senior Scientist since February 2023. Before that, they held the position of Scientist I at Congruence Therapeutics from August 2022 to February 2023. Prior to their work at Congruence Therapeutics, Sandra worked as an Assistant Scientist II at Domain therapeutics DTNA from July 2014 to November 2021. Sandra also served as an Assistant Researcher at Klox Technologies from September 2009 to July 2014. Sandra's earlier experience includes working as a Research Associate II at BELLUS Health (formerly known as Neurochem Inc.) and as a Research Assistant II at Neurochem, both from an unspecified date in 2005 to an unspecified date in 2008. Additionally, they worked as a Research Assistant at Hôpital Sainte-Justine from November 2001 to December 2004 and at Hôpital Général de Montréal from March 2000 to September 2000.

Sandra Morissette's education history shows that they obtained a Bachelor's degree in Biochemistry from the Université de Montréal from 1992 to 1995. Following that, they pursued further studies at Paris-Sud University (Paris XI) from 1997 to 1999, where they completed a DEA (Diplôme d'Études Approfondies) in Biochemistry.